当前位置:首页 - 行情中心 - *ST目药(600671) - 财务分析 - 资产负债表

*ST目药

(600671)

  

流通市值:9.68亿  总市值:9.68亿
流通股本:1.22亿   总股本:1.22亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金100,946,411.366,822,724.2727,107,954.5642,392,496.34
应收票据及应收账款29,511,700.0830,742,457.5330,768,964.3730,806,029.81
应收账款29,511,700.0830,742,457.5330,768,964.3730,806,029.81
应收款项融资1,284,845.03-1,228,147184,286.4
预付款项5,424,413.054,991,371.461,444,000.751,020,030.87
其他应收款合计1,739,589.162,720,119.331,795,352.971,788,499.41
存货41,848,675.4947,048,527.349,221,169.1147,560,717.66
其他流动资产302,408.98564,348.86885,970.27381,005.42
流动资产平衡项目0000
流动资产合计181,058,043.1592,889,548.75112,451,559.03124,133,065.91
非流动资产:
固定资产139,318,443.01142,322,140.31151,174,012.47154,242,980.75
在建工程449,601.5416,858.14405,010.62110,033
使用权资产9,985,993.7510,838,117.629,753,938.1510,584,032.79
无形资产5,253,623.55,292,321.45,331,019.35,369,717.2
商誉2,198,559.522,198,559.522,198,559.522,198,559.52
长期待摊费用1,453,957.131,924,022.522,171,245.162,477,157.98
递延所得税资产724,280.27724,280.27724,280.27724,280.27
非流动资产平衡项目0000
非流动资产合计159,384,458.68163,716,299.78171,758,065.49175,706,761.51
资产平衡项目0000
资产总计340,442,501.83256,605,848.53284,209,624.52299,839,827.42
流动负债:
短期借款102,500,000104,579,301.29104,503,818.03104,642,762.49
应付票据及应付账款39,705,120.8538,614,908.5546,724,302.9247,222,617.09
应付账款39,705,120.8538,614,908.5546,724,302.9247,222,617.09
合同负债3,341,854.452,955,364.883,956,573.043,583,954.69
应付职工薪酬5,288,626.195,733,853.296,641,822.958,152,180.95
应交税费2,146,270.881,788,991.21,418,264.882,431,746.51
其他应付款合计135,756,905.8947,092,933.2449,358,968.0750,799,257.45
应付股利23,403.3623,403.3623,403.3623,403.36
一年内到期的非流动负债3,599,458.283,599,458.283,599,458.283,898,496.58
其他流动负债433,201.07383,680.47438,651.21489,639.6
流动负债平衡项目0000
流动负债合计292,771,437.61204,748,491.2216,641,859.38221,220,655.36
非流动负债:
租赁负债6,655,797.46,643,826.377,593,812.587,463,103.9
预计负债1,430,319.761,430,319.761,430,319.761,430,319.76
递延收益61,946,447.6762,946,610.4664,037,778.6665,246,020.09
非流动负债平衡项目0000
非流动负债合计70,032,564.8371,020,756.5973,061,91174,139,443.75
负债平衡项目0000
负债合计362,804,002.44275,769,247.79289,703,770.38295,360,099.11
所有者权益(或股东权益):
实收资本(或股本)121,778,885121,778,885121,778,885121,778,885
资本公积72,787,915.9872,787,915.9872,787,915.9872,787,915.98
盈余公积24,181,414.3724,181,414.3724,181,414.3724,181,414.37
未分配利润-260,833,486.2-256,796,528.53-242,430,587.6-233,375,486.67
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计-42,085,270.85-38,048,313.18-23,682,372.25-14,627,271.32
少数股东权益19,723,770.2418,884,913.9218,188,226.3919,106,999.63
股东权益平衡项目0000
股东权益合计-22,361,500.61-19,163,399.26-5,494,145.864,479,728.31
负债和股东权益合计340,442,501.83256,605,848.53284,209,624.52299,839,827.42
公告日期2023-10-282023-08-312023-04-262023-04-26
审计意见(境内)带强调事项段的无保留意见
TOP↑